Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$0.39 - $0.71 $25,055 - $45,613
64,245 Added 3.51%
1,896,552 $796,000
Q4 2022

Feb 13, 2023

BUY
$0.33 - $10.44 $10,494 - $331,992
31,800 Added 1.77%
1,832,307 $737,000
Q3 2022

Nov 14, 2022

BUY
$0.92 - $11.16 $7,307 - $88,643
7,943 Added 0.44%
1,800,507 $1.53 Million
Q2 2022

Aug 12, 2022

SELL
$1.02 - $1.83 $1.38 Million - $2.47 Million
-1,349,539 Reduced 42.95%
1,792,564 $2.08 Million
Q1 2022

May 13, 2022

BUY
$1.06 - $2.1 $207,248 - $410,585
195,517 Added 6.64%
3,142,103 $4.43 Million
Q4 2021

Feb 11, 2022

BUY
$2.05 - $3.2 $293,535 - $458,201
143,188 Added 5.11%
2,946,586 $6.04 Million
Q3 2021

Nov 12, 2021

BUY
$2.54 - $4.07 $39,598 - $63,451
15,590 Added 0.56%
2,803,398 $8.63 Million
Q2 2021

Aug 13, 2021

BUY
$2.57 - $4.85 $114,868 - $216,775
44,696 Added 1.63%
2,787,808 $11.3 Million
Q1 2021

May 12, 2021

BUY
$1.9 - $2.82 $674,408 - $1 Million
354,952 Added 14.86%
2,743,112 $6.78 Million
Q4 2020

Feb 12, 2021

BUY
$1.15 - $2.4 $192,003 - $400,704
166,960 Added 7.52%
2,388,160 $5.09 Million
Q3 2020

Nov 13, 2020

BUY
$1.11 - $1.68 $139,079 - $210,498
125,297 Added 5.98%
2,221,200 $2.69 Million
Q2 2020

Aug 13, 2020

BUY
$1.69 - $4.2 $1.84 Million - $4.58 Million
1,090,641 Added 108.49%
2,095,903 $3.6 Million
Q1 2020

May 14, 2020

BUY
$1.26 - $3.38 $405,641 - $1.09 Million
321,938 Added 47.11%
1,005,262 $2.65 Million
Q4 2019

Feb 13, 2020

BUY
$0.86 - $1.44 $1,464 - $2,452
1,703 Added 0.25%
683,324 $915,000
Q3 2019

Nov 12, 2019

SELL
$1.21 - $1.59 $12,567 - $16,513
-10,386 Reduced 1.5%
681,621 $824,000
Q2 2019

Aug 14, 2019

SELL
$1.25 - $3.14 $251,172 - $630,945
-200,938 Reduced 22.5%
692,007 $1.04 Million
Q1 2019

May 14, 2019

BUY
$2.79 - $4.09 $209,760 - $307,498
75,183 Added 9.19%
892,945 $2.64 Million
Q4 2018

Feb 13, 2019

BUY
$3.23 - $7.01 $26,928 - $58,442
8,337 Added 1.03%
817,762 $2.75 Million
Q3 2018

Nov 13, 2018

BUY
$6.86 - $9.97 $2.07 Million - $3.01 Million
302,191 Added 59.58%
809,425 $5.87 Million
Q2 2018

Aug 14, 2018

BUY
$2.88 - $8.67 $738,501 - $2.22 Million
256,424 Added 102.24%
507,234 $3.49 Million
Q1 2018

May 15, 2018

BUY
$2.92 - $3.81 $59,311 - $77,388
20,312 Added 8.81%
250,810 $747,000
Q4 2017

Feb 13, 2018

BUY
$2.99 - $4.85 $16,059 - $26,049
5,371 Added 2.39%
230,498 $707,000
Q3 2017

Nov 14, 2017

BUY
$3.01 - $5.41 $99,980 - $179,698
33,216 Added 17.31%
225,127 $1.06 Million
Q2 2017

Aug 14, 2017

BUY
N/A
191,911
191,911 $418,000

Others Institutions Holding VSTM

About Verastem, Inc.


  • Ticker VSTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 210,000,000
  • Market Cap $1.12B
  • Description
  • Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...
More about VSTM
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.